Leerink Partners Resumes Aquinox Pharmaceutical (AQXP) at Outperform
Tweet Send to a Friend
Leerink Partners resumes coverage on Aquinox Pharmaceutical (NASDAQ: AQXP) with a Outperform rating and a price target of $24.00.Analyst Paul ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE